Supriya Lifescience Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience Limited has submitted its financial results for the quarter and period ended December 31, 2025 to the stock exchange. The announcement is a routine regulatory filing under SEBI's listing obligations and does not include detailed numbers in the headline. Investors will need to review the full results document to assess revenue, profit, margins, and other key metrics. No specific figures, growth rates, or auditor observations are visible in the provided excerpt.
This is a standard compliance filing, not an event-driven announcement. Any meaningful impact on the stock or shareholders will depend on the actual numbers in the full results — particularly revenue growth, PAT movement, and margin trends versus previous quarters.